Table 1

Population demographics at baseline and follow-up

Baseline, n=50Follow-up, n=50
Age, Median (IQR)42 (20)
Female, n (%)42 (84.0)
Duration of BoT-A, Median (IQR)13.5 (27)
VAS, Median (IQR)6 (3)4 (2.9)
MHD, Median (IQR)8 (12)8 (13)
  • BoT-A, onabotulinumtoxinA; MHD, monthly headache days; VAS, Visual Analogue Score.